Janux Therapeutics, Inc.

NasdaqGM:JANX Stock Report

Market Cap: US$2.6b

Janux Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:JANX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
01 Nov 24SellUS$24,385,695Avalon Ventures, LLCCompany456,267US$55.26
01 Nov 24SellUS$391,382Sanford MadiganIndividual7,371US$53.12
01 Nov 24SellUS$243,671Jay LichterIndividual4,558US$53.51
01 Nov 24SellUS$1,730,817Tighe ReardonIndividual32,384US$53.82
01 Nov 24SellUS$334,250Sergio DuronIndividual6,306US$53.02
01 Nov 24SellUS$2,337,413Avalon Bio VenturesCompany43,734US$55.26
24 Oct 24SellUS$262,634Jay LichterIndividual4,921US$53.37
24 Oct 24SellUS$1,802,808Tighe ReardonIndividual34,799US$52.77
23 Oct 24SellUS$25,244,312Avalon Ventures, LLCCompany492,469US$53.36
23 Oct 24SellUS$408,358Sanford MadiganIndividual7,954US$51.34
23 Oct 24SellUS$350,101Sergio DuronIndividual6,806US$51.44
23 Oct 24SellUS$2,419,661Avalon Bio VenturesCompany47,203US$53.36
18 Oct 24SellUS$21,101,095Avalon Ventures, LLCCompany420,066US$51.18
18 Oct 24SellUS$2,022,474Avalon Bio VenturesCompany40,262US$51.18
18 Oct 24BuyUS$53,700,000RA Capital Management, L.P.Company1,200,000US$44.75
18 Oct 24SellUS$49,003,174Avalon Ventures, LLCCompany1,095,043US$44.75
18 Oct 24SellUS$4,696,826Avalon Bio VenturesCompany104,957US$44.75
17 Oct 24SellUS$26,155Jay LichterIndividual516US$50.80
30 Sep 24SellUS$5,221Jay LichterIndividual113US$46.24
27 Sep 24SellUS$12,924,676Avalon Ventures, LLCCompany275,255US$47.77
27 Sep 24SellUS$1,239,338Avalon Bio VenturesCompany26,394US$47.77
27 Sep 24SellUS$145,750Avalon Ventures, LLCCompany3,053US$47.74
27 Sep 24SellUS$13,988Avalon Bio VenturesCompany293US$47.74
12 Sep 24SellUS$1,850,216Avalon Bio VenturesCompany39,455US$47.00
12 Sep 24SellUS$19,303,403Avalon Ventures, LLCCompany411,636US$47.00
09 Sep 24SellUS$9,198,378Avalon Ventures, LLCCompany219,009US$42.00
09 Sep 24SellUS$3,513Jay LichterIndividual83US$42.33
09 Sep 24SellUS$881,622Avalon Bio VenturesCompany20,991US$42.00
31 Jul 24SellUS$61,511,990OrbiMed Advisors LLCCompany1,312,787US$55.01
03 Jun 24SellUS$74,942,019Avalon Ventures, LLCCompany1,368,804US$54.75
03 Jun 24SellUS$7,182,981Avalon Bio VenturesCompany131,196US$54.75
02 Mar 24SellUS$757,732Sanford MadiganIndividual16,341US$46.37
02 Mar 24SellUS$560,125Sergio DuronIndividual12,343US$45.38

Insider Trading Volume

Insider Buying: JANX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of JANX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders4,109,8487.66%
VC/PE Firms10,365,65219.3%
Institutions39,160,07773%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13.7%.

Top Shareholders

Top 25 shareholders own 90.27% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.8%
RA Capital Management, L.P.
10,365,652US$521.5m13.1%6.0%
14.9%
FMR LLC
7,824,671US$393.7m0.61%0.02%
5.72%
Klaus Dorner
2,999,990US$150.9m-21.7%no data
4.97%
Paradigm Biocapital Advisors LP
2,608,574US$131.2m8.66%4.28%
4.81%
Janus Henderson Group plc
2,523,406US$127.0m40%0.05%
4.62%
BlackRock, Inc.
2,422,636US$121.9m3.35%no data
3.95%
Adage Capital Management, L.P.
2,075,000US$104.4m-10.9%0.16%
3.56%
Avalon Ventures, LLC
1,869,633US$94.1m-67.2%81.51%
3.52%
The Vanguard Group, Inc.
1,847,930US$93.0m18.3%no data
3.05%
Woodline Partners LP
1,600,263US$80.5m432%0.62%
2.8%
EcoR1 Capital, LLC
1,469,818US$73.9m0%2.41%
2.59%
State Street Global Advisors, Inc.
1,361,178US$68.5m-2.86%no data
2.4%
OrbiMed Advisors LLC
1,258,566US$63.3m-57.8%0.8%
2%
Cormorant Asset Management, LP
1,050,000US$52.8m0%2.35%
1.92%
Citadel Advisors LLC
1,009,768US$50.8m-35.2%0.05%
1.91%
Logos Global Management, L.P.
1,000,000US$50.3m33.3%5.56%
1.34%
Lord, Abbett & Co. LLC
703,481US$35.4m0.12%0.1%
1.26%
Geode Capital Management, LLC
662,594US$33.3m6.17%no data
1.07%
Avidity Partners Management, L.P.
562,000US$28.3m-33.1%1.45%
0.92%
Vestal Point Capital, LP
485,000US$24.4m-33.1%1.84%
0.9%
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.
471,736US$23.7m0%0.2%
0.75%
Point72 Asset Management, L.P.
395,875US$19.9m190%0.05%
0.54%
David Campbell
282,054US$14.2m-89.3%no data
0.51%
Northern Trust Global Investments
266,498US$13.4m37.1%no data
0.49%
Goldman Sachs Group, Investment Banking and Securities Investments
257,400US$12.9m-14.2%0.01%